WR-1065, the active metabolite of amifostine (Ethyol), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells.
- DOI
- 10.1016/s0959-8049(96)00313-9
- Published
- 1996
- Container
- European journal of cancer (Oxford, England : 1990)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0959-8049-96-00313-9,
title = {WR-1065, the active metabolite of amifostine (Ethyol), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells.},
author = {Alberts DS and Speicher LA and Krutzsch M and Wymer J and Capizzi RL and Conlon J and Barrett A and Aickin M},
year = {1996},
journal = {European journal of cancer (Oxford, England : 1990)},
doi = {10.1016/s0959-8049(96)00313-9},
url = {https://doi.org/10.1016/s0959-8049(96)00313-9}
}RIS
TY - JOUR TI - WR-1065, the active metabolite of amifostine (Ethyol), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells. AU - Alberts DS AU - Speicher LA AU - Krutzsch M AU - Wymer J AU - Capizzi RL AU - Conlon J AU - Barrett A AU - Aickin M PY - 1996 JO - European journal of cancer (Oxford, England : 1990) DO - 10.1016/s0959-8049(96)00313-9 UR - https://doi.org/10.1016/s0959-8049(96)00313-9 ER -
APA
DS, A., LA, S., M, K., J, W., RL, C., J, C., A, B., & M, A. (1996). WR-1065, the active metabolite of amifostine (Ethyol), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/s0959-8049(96)00313-9
Source records
- pubmed · retrieved 2026-09-26T08:44:41.487Z